PMID: 2487155Nov 1, 1989Paper

Recurring loss involving chromosomes 1, 3, and 22 in malignant mesothelioma: possible sites of tumor suppressor genes

Genes, Chromosomes & Cancer
W L FlejterJ R Testa

Abstract

Cytogenetic analysis was performed on short-term cultures of primary tumor tissue obtained from five patients with pleural malignant mesothelioma. Clonal karyotypic abnormalities were detected in four patients, none of whom had received cytotoxic therapy prior to karyotypic evaluation. Recurring chromosomal changes included partial deletions of 1p and 3p, and monosomy of 18, 19, and 22. We also reviewed data on 24 previously reported pretreatment patients and determined that alterations of chromosomes 1, 3, and 22 are frequently associated with malignant mesothelioma. Partial loss of chromosome 1 due to deletions or other rearrangements most frequently involve bands 1p11-pter with the shortest region of overlap (SRO) occurring at 1p21-p22 in our patients. Deletions and other structural changes of chromosome 3 usually involve the region 3p14-p25. The SRO of 3p deletions appeared to be at band 3p21. Monosomy 22 represents the most consistent specific whole chromosome loss seen in malignant mesothelioma, being observed in 11 of 28 cases summarized. In addition, structural changes of 22q have been observed in three patients, and a breakpoint at 22q11 was reported in each case. Taken collectively, these data suggest that a cascade o...Continue Reading

References

Jan 1, 1979·Cytogenetics and Cell Genetics·U FranckeV M Riccardi
Jan 1, 1989·Cancer Genetics and Cytogenetics·J R Teyssier
Jun 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·J F LechnerC C Harris
Jul 15, 1988·Cancer Genetics and Cytogenetics·M TiainenS Knuutila
Jan 1, 1988·Cytogenetics and Cell Genetics·J M TrentF Mitelman
Jun 1, 1987·Cancer Genetics and Cytogenetics·Y S Fan, P Li
Feb 15, 1986·Cancer Genetics and Cytogenetics·Z GibasA A Sandberg
Jan 1, 1970·Chromosoma·T CasperssonE J Modest
Jun 17, 1982·The New England Journal of Medicine·J E Craighead, B T Mossman
Jun 1, 1981·Human Pathology·J J Yunis

❮ Previous
Next ❯

Citations

Jan 1, 1992·American Journal of Industrial Medicine·C WalkerJ C Barrett
May 1, 1991·Genes, Chromosomes & Cancer·J Whang-PengJ D Minna
Sep 1, 1991·Genes, Chromosomes & Cancer·A J KlingelhutzC A Reznikoff
Jan 1, 1994·Genes, Chromosomes & Cancer·Y Y LuJ R Testa
Jun 1, 1994·Genes, Chromosomes & Cancer·M H RuttledgeJ P Dumanski
Aug 1, 1994·Genes, Chromosomes & Cancer·G SchleiermacherO Delattre
Jan 1, 1996·Journal of Cellular Biochemistry. Supplement·H I Pass, D J Mew
Aug 1, 1991·Cancer Genetics and Cytogenetics·P Dal CinH Van den Berghe
Jul 15, 1992·Cancer Genetics and Cytogenetics·S WeremowiczJ A Fletcher
May 1, 1992·Cancer Genetics and Cytogenetics·S PyrhönenS Knuutila
Oct 15, 1993·Cancer Genetics and Cytogenetics·I L HansteenA Haugen
Jan 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G SchleiermacherO Delattre
Oct 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M Huncharek
Jun 27, 2001·Cancer Genetics and Cytogenetics·A A Sandberg, J A Bridge
May 22, 1998·Cancer Genetics and Cytogenetics·M R TeixeiraS Heim
Aug 30, 2011·Nature Genetics·Joseph R TestaMichele Carbone
May 3, 2011·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Jennifer E BelowJoseph R Testa
Mar 12, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A BuhmeidaS Pyrhönen
Dec 24, 1997·Environmental Health Perspectives·J F LechnerB I Gerwin
Mar 1, 2012·Archives of Pathology & Laboratory Medicine·Didier JeanMarie-Claude Jaurand
Sep 14, 1992·Biochimica Et Biophysica Acta·M Schwab
Feb 1, 1993·International Journal of Cancer. Journal International Du Cancer·K OokawaJ Yokota
Dec 28, 2007·Cytogenetic and Genome Research·P M LindholmS Knuutila
Dec 9, 1998·Cancer Investigation·G L Applegate, M H Marymont
Jan 24, 2013·Genes, Chromosomes & Cancer·Veronica HöiomJohan Hansson
Sep 13, 2006·Cancer Genetics and Cytogenetics·Marina MustiSakari Knuutila
Sep 23, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Paolo A Zucali, Giuseppe Giaccone
Oct 12, 2005·Cancer Letters·Bryan A Whitson, Robert A Kratzke
Feb 14, 1991·The New England Journal of Medicine·J A FletcherJ M Corson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved